Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04496362 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Sep 2026 to Feb 12, 2025
    • Study completion date: Dec 2026 to Jun 2026
    • Site details revised
    v6
  2. Primary completion date: Sep 2023 to Sep 2026
    • Study completion date: Dec 2023 to Dec 2026
    • Site contact updated
    v5
  3. Site contact updatedv4
  4. Primary completion date: Sep 2021 to Sep 2023
    • Study completion date: Dec 2021 to Dec 2023
    v3
  5. Study description expanded, about 1 wordv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This single-center, open-label study will evaluate the safety and efficacy of subcutaneous heparin anticoagulation compared to the standard of care systemic intravenous anticoagulation during veno-venous extracorporeal membrane oxygenation for respiratory failure.
Trial Details
NCT Number NCT04496362
Lead Sponsor Baylor Research Institute
Conditions
(from sponsor)		 ECMO, Heparin, Respiratory Failure
Related terms Respiratory Insufficiency
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov